Amina Ammar: Evaluating Rivaroxaban Dosing Alignment Across Cockcroft–Gault and eGFR Equations
Amina Ammar, Clinical Pharmacist at Henry Ford Wyandotte Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authered, published in Journal of Thrombosis and Thrombolysis, adding:
“Excited to share our latest publication in the Journal of Thrombosis and Thrombolysis!
Our study used data from the Michigan Anticoagulation Quality Improvement Initiative (MAQI²) Registry to evaluate differences in rivaroxaban dosing based on the method used to estimate renal function.
Grateful to everyone who contributed to this work! ”
Title: Disagreement in rivaroxaban dosing between Cockcroft–Gault and eGFR equations in nonvalvular atrial fibrillation
Authors: Amina Ammar, Stephanie Edwin, Geoffrey D. Barnes, Scott Kaatz, Deborah DeCamillo, Xiaowen Kong, Brian Haymart, Noelle Ryan, Christopher Giuliano
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience